共 167 条
[1]
Satsangi J(2006)The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications Gut 55 749-753
[2]
Silverberg MS(2015)Management of perianal fistulas in Crohn’s disease: an up-to-date review World J Gastroenterol 21 1394-273
[3]
Vermeire S(2017)Surgical management of fistulating perianal Crohn’s disease—a UK survey Colorectal Dis 19 266-1392
[4]
Colombel J-F(2014)A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease Gut 63 1381-1285
[5]
Marzo M(2014)Crohn’s disease BMJ 349 g6670-1239
[6]
Lee MJ(2010)Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate-to-severe Crohn’s disease in the precise 2 study Aliment Pharmacol Ther 31 1276-518
[7]
Heywood N(2010)The CHOICE trial: Adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohns disease who failed prior infliximab therapy Aliment Pharmacol Ther 32 1228-316
[8]
Sagar PM(2014)Improving the outcome of fistulising Crohn’s disease Best Pract Res Clin Gastroenterol 28 505-3406
[9]
Gecse KB(2012)Endoscopic ultrasound for perianal Crohn’s disease: disease and fistula characteristics, and impact on therapy J Crohns Colitis 6 311-970
[10]
Bemelman W(2013)Health care costs of complex perianal fistula in Crohn’s disease Dig Dis Sci 58 3400-986